Helocyte

New York, United States

Helocyte is a clinical-stage biopharmaceutical company developing novel immunotherapies for the prevention and treatment of cancer.

$3.2M raised

Jun 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Helocyte raised?

Helocyte has raised $3.2M in total funding. The most recent round was Grant. The last funding was announced in June 2023.

Who are Helocyte's investors?

Helocyte's investors include SternAegis, National Cancer Institute.

Where is Helocyte headquartered?

Helocyte is headquartered in New York, United States.

What does Helocyte do?

Helocyte is a clinical-stage biopharmaceutical company developing novel immunotherapies for the prevention and treatment of cancer.

What stage is Helocyte at?

Helocyte is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 15, 2023.

MLA

"Helocyte — Funding & Investors." VCBacked, June 15, 2023, https://www.vcbacked.co/company/helocyte. Accessed July 3, 2026.

APA

VCBacked. (2023). Helocyte — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/helocyte

Wikipedia (cite web)

{{cite web |title=Helocyte — Funding & Investors |url=https://www.vcbacked.co/company/helocyte |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 15, 2023.